ArticleJACC. Case reports2026
Ablation of Intra-Atrial Re-Entrant Tachycardia in an Adult With Double-Inlet Ventricle Using Pulsed-Field Ablation.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Ablation in Complex Adult Congenital Heart Disease: Versatility Matters.JACC. Case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSupraventricular tachycardia is common in patients with adult congenital heart disease and carries a high morbidity. Ablation of these arrhythmias is an effective treatment strategy, but difficulty accessing the cardiac chambers, variations in electroanatomical circuits, and concerns of damaging the surrounding structures can pose procedural challenges. CASE SUMMARY: A 45-year-old man with complex congenital heart disease and intra-atrial re-entrant tachycardia initially underwent ablation with radiofrequency energy but experienced clinical recurrence. He presented for a second procedure using pulsed-field ablation (PFA), which was successful. DISCUSSION: PFA is emerging as a safe and effective energy delivery system for ablation of different cardiac arrhythmias. It may be effective in adult congenital heart disease patients with atrial fibrillation. TAKE-HOME MESSAGE: PFA is safe and effective for treatment of supraventricular tachycardia in the adult congenital heart disease population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.